Supreme Court directs Centre to formulate no-fault compensation policy for serious COVID-19 vaccine adverse events

The Supreme Court’s Mandate on No-Fault Compensation: A Landmark Shift in Public Health Accountability

In a significant development that underscores the evolving landscape of Indian constitutional law, the Supreme Court of India has directed the Union Government to formulate a comprehensive “no-fault” compensation policy for individuals who have suffered serious adverse events following COVID-19 vaccinations (AEFI). This directive, issued to the Ministry of Health and Family Welfare, marks a departure from traditional tortious liability and moves toward a more compassionate, social-security-based approach to public health. As a senior advocate, it is imperative to parse the legal, ethical, and constitutional dimensions of this order, which seeks to balance the “greater good” of mass immunization with the fundamental rights of the individual.

The core of the matter lies in the recognition that while the COVID-19 vaccination drive was a monumental success in safeguarding the population, a small but significant number of citizens faced severe medical complications. Until now, the burden of proving that these complications were directly caused by the vaccine—and that such harm resulted from negligence—rested on the shoulders of the grieving families or the survivors. By advocating for a “no-fault” framework, the Supreme Court has effectively removed the prohibitive hurdle of proving negligence, ensuring that the state fulfills its role as a welfare entity.

The Doctrine of No-Fault Liability in the Context of Vaccination

To understand the weight of this directive, one must understand the distinction between “fault-based” and “no-fault” liability. In traditional civil law, for a victim to claim compensation, they must establish that the defendant owed a duty of care, breached that duty (negligence), and that the breach directly caused the injury. In the case of vaccines developed under emergency use authorizations during a global pandemic, proving clinical negligence against a manufacturer or the state is an almost impossible evidentiary task for an average citizen.

Eliminating the Burden of Proof

A “no-fault” compensation scheme operates on the principle of strict liability. Under this framework, the claimant does not need to prove that the vaccine was “defective” or that the medical professional was “negligent.” Instead, they only need to establish a temporal and medical link between the administration of the vaccine and the occurrence of a serious adverse event. This approach acknowledges that even with the highest standards of manufacturing and administration, biological variations mean that a tiny fraction of the population may react adversely to any vaccine. The Court’s rationale is that since these individuals took the risk for the collective safety of the nation, the nation must bear the cost of their misfortune.

The Social Contract and Public Health

From a legal standpoint, this directive reinforces the social contract between the state and its citizens. When the state encourages or mandates a particular medical intervention for the sake of public health, it enters into an implied agreement to protect those who might be harmed by that very intervention. The Supreme Court is essentially stating that the state cannot enjoy the benefits of “herd immunity” without providing a safety net for those who pay the price for it.

Constitutional Mandates: Article 21 and the Right to Health

The Supreme Court’s order finds its deepest roots in Article 21 of the Constitution of India, which guarantees the Right to Life and Personal Liberty. The judiciary has long interpreted this article to include the “Right to Health.” In the context of a pandemic, the state’s duty to protect life involves not just the distribution of vaccines but also the mitigation of any harm caused by such measures.

Article 14 and the Principle of Equality

Furthermore, the principle of equality under Article 14 is invoked. Leaving victims of vaccine injuries to navigate the arduous and expensive corridors of civil litigation, while others benefit from the same vaccination program without incident, creates an unfair disparity. A streamlined no-fault policy ensures that all citizens are treated with equal dignity and provided with an accessible mechanism for redressal, regardless of their socio-economic standing or ability to hire expert medical witnesses.

The Welfare State and Parens Patriae

The directive also touches upon the doctrine of parens patriae, where the state acts as the guardian of those who cannot protect themselves. By ordering the Ministry of Health and Family Welfare to frame this policy, the Court is reminding the executive that in matters of public health emergencies, the state’s role is not merely administrative but protective and compensatory.

Global Precedents and the Indian Scenario

India is not alone in grappling with this issue. Many developed nations have had vaccine injury compensation programs (VICPs) for decades. For instance, the United Kingdom has the Vaccine Damage Payment Act of 1979, and the United States has a robust National Vaccine Injury Compensation Program. These systems are designed to be non-adversarial, providing a faster and less traumatic route for victims than the court system.

The COVAX Model

Even at the international level, the WHO-led COVAX facility established a no-fault compensation program for 92 low- and middle-income countries. The Supreme Court’s direction ensures that India aligns its domestic policy with these global standards of bioethics and social justice. It addresses a vacuum in the Indian legislative framework where, despite being the “pharmacy of the world,” we lacked a statutory safety net for vaccine-related injuries.

The Role of the National AEFI Committee

Currently, India has a mechanism for monitoring Adverse Events Following Immunization (AEFI), overseen by the National AEFI Committee. However, the committee’s primary role has been data collection and causality assessment for public health tracking, rather than compensation. The Supreme Court’s order necessitates a transformation of this data-driven process into a remedy-driven process.

Challenges in Policy Formulation for the Union Government

While the Court’s directive is clear, the implementation by the Ministry of Health and Family Welfare involves complex administrative and medical challenges. The government must define what constitutes a “serious adverse event” and establish clear, science-based criteria for causality.

Defining Causality and Severity

One of the primary hurdles will be distinguishing between coincidental medical events and those actually triggered by the vaccine. Since the policy is “no-fault,” the criteria for “causality” should not be so stringent that they defeat the purpose of the scheme, yet they must be robust enough to prevent fraudulent claims. The policy will likely need to categorize events such as anaphylaxis, GBS (Guillain-Barré Syndrome), or specific cardiovascular events that have been documented in clinical literature as potential vaccine reactions.

Funding and Sustainability

Another critical aspect is the funding of the compensation pool. Should the funds come directly from the exchequer, or should there be a levy on vaccine manufacturers? In many jurisdictions, a small “tax” or fee per dose is diverted into a compensation fund. Given that the COVID-19 vaccines were often purchased and distributed by the government, the initial responsibility will likely rest with the Centre, perhaps supported by the Disaster Management Fund.

Addressing Vaccine Hesitancy through Transparency

A significant byproduct of a no-fault compensation policy is the enhancement of public trust. Vaccine hesitancy often stems from a fear of the unknown and a feeling that if something goes wrong, the individual will be left to fend for themselves. By publicly acknowledging the possibility of adverse events and providing a guaranteed path for support, the government actually strengthens the vaccination program.

Transparency as a Tool for Public Health

Transparency regarding side effects and the availability of compensation demonstrates that the state is confident in its vaccine program but also honest about the inherent risks. This honesty is the cornerstone of public health ethics. When the state takes responsibility, it diminishes the power of misinformation and “anti-vax” narratives, as the conversation shifts from “denial of risk” to “management of risk.”

The Procedural Path Forward: What Claimants Can Expect

Following the Supreme Court’s order, the Union Government is expected to present a draft framework. This framework should ideally include an independent medical board to review applications, a time-bound disposal mechanism, and a standardized compensation scale based on the severity of the injury or, in tragic cases, loss of life.

Non-Adversarial Grievance Redressal

The beauty of a no-fault system is that it should be non-adversarial. Instead of a courtroom battle between a citizen and the government’s lawyers, the process should resemble an insurance claim or a social security application. The focus should be on medical records and the findings of the AEFI committees rather than legal arguments over “breach of duty.”

The Right to Appeal

While the process is intended to be streamlined, the policy must also include a mechanism for appeal. If a claim is rejected by the medical board, the citizen must have the right to challenge that finding before an independent tribunal or a judicial body, ensuring that the principles of natural justice are maintained throughout the process.

Conclusion: A New Era of Legal Protection in Public Health

The Supreme Court’s direction to formulate a no-fault compensation policy for COVID-19 vaccine adverse events is a landmark moment in Indian legal history. It represents a synthesis of medical science, constitutional law, and social empathy. As we move forward, this policy could serve as a blueprint for all future mass immunization programs, not just for COVID-19. It acknowledges that in the pursuit of the collective good, the individual cannot be treated as collateral damage.

As members of the legal fraternity, we must welcome this move as a victory for the common man. It reinforces the idea that the judiciary remains the ultimate sentinel on the qui vive, protecting the rights of the citizen against the might of the state, even in times of national crisis. The transition from “fault” to “responsibility” is not just a legal change; it is a moral one, reflecting the maturity of our democracy and its commitment to the dignity and well-being of every citizen.

The Ministry of Health and Family Welfare now carries the mantle of translating this judicial vision into an executive reality. The resulting policy will be watched closely, as it will define the future of state accountability in the face of public health challenges. For the families affected by serious vaccine adverse events, this order offers more than just the prospect of financial aid; it offers the validation that their sacrifice is recognized and that the law stands with them in their time of need.